Biotechnology FDA Approves Mirum’s Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy – Mirum Pharmaceuticals (NASDAQ:MIRM) Read more
Stockmarkets Biden’s reelection campaign joins TikTok in push for young voters Reuters via biedexmarkets.com Read more